veliparib,pembrolizumab
merck,abbvie
[]
dr discussed long-term results from nrg-gi002: a phase ii clinical trial platform using total neoadjuvant therapy (tnt) in locally advanced rectal cancer (larc).conclusions below #gi23 #crcsm 
#Cancer survivor, patient #advocate, Public #speaker, @AmericanCancer Director Project ECHO, @MDAndersonNews @SWOG volunteer. #crcsm #ayacsm Views my own